Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million ...Middle East

Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol) Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik volume in the U.S. while reducing gross-to-net...

Hence then, the article about valinor pharma announces acquisition by grunenthal with a total deal value of approximately 250 million was published today ( Monday 22/07/2024 - 08:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million )

Also on site :

• Sam's Club Delights Shoppers By Bringing Back One of its Top-Selling Snacks: 'I Am Completely Addicted'
• Anthropic says engineering missteps were behind Claude Code’s monthlong decline after weeks of user backlash
• 1990s Country King Shares Exciting Update on 2026 Tour: 'Let's Do This'